Nationwide Fund Advisors’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-68,238
Closed -$2.53M 2730
2017
Q3
$2.53M Buy
68,238
+153
+0.2% +$5.64K 0.01% 1335
2017
Q2
$2.59M Sell
68,085
-12,510
-16% -$557K 0.01% 1319
2017
Q1
$3.94M Sell
80,595
-78,785
-49% -$3.59M 0.02% 1095
2016
Q4
$5.41M Sell
159,380
-2,880
-2% -$102K 0.02% 945
2016
Q3
$6.12M Buy
162,260
+70,816
+77% +$2.67M 0.03% 863
2016
Q2
$3.08M Sell
91,444
-4,894
-5% -$173K 0.01% 1172
2016
Q1
$3.08M Buy
96,338
+7,724
+9% +$252K 0.01% 1158
2015
Q4
$3.31M Sell
88,614
-530
-0.6% -$20K 0.01% 1136
2015
Q3
$3.38M Sell
89,144
-29,022
-25% -$1.02M 0.02% 1115
2015
Q2
$3.38M Sell
118,166
-18,047
-13% -$503K 0.01% 1152
2015
Q1
$3.82M Sell
136,213
-10,941
-7% -$307K 0.02% 1114
2014
Q4
$4.07M Sell
147,154
-2,922
-2% -$72.4K 0.02% 1048
2014
Q3
$3.35M Buy
150,076
+14,881
+11% +$378K 0.01% 1162
2014
Q2
$3.93M Buy
135,195
+23,102
+21% +$617K 0.02% 1123
2014
Q1
$3.19M Sell
112,093
-87,295
-44% -$2.89M 0.01% 1099
2013
Q4
$7.7M Buy
199,388
+81,084
+69% +$2.9M 0.03% 706
2013
Q3
$3.97M Sell
118,304
-37,909
-24% -$1.21M 0.02% 1037
2013
Q2
$4.8M Buy
+156,213
New +$5.23M 0.03% 827

Other funds holding MDCO

Nationwide Fund Advisors's MDCO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Medicines Co (MDCO) in Q4 2017, closing a stake of 68,238 shares — an estimated $2.53M sold.

Nationwide Fund Advisors first reported a position in MDCO in Q2 2013 and held it in 18 quarters. The position peaked at $7.7M in Q4 2013. 202 funds tracked by Wall St. Rank hold MDCO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Medicines Co position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 68,238 Medicines Co shares in Q4 2017, an estimated $2.53M.
  • Nationwide Fund Advisors first reported a position in Medicines Co in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Medicines Co position peaked at $7.7M in Q4 2013.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.